Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Milestone Pharmaceuticals Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −9 vs. Q2 2023
- Shares held
- 19.6M
- −1.12M (−5.4%) vs. Q2 2023
- Total value
- $60.7M
- +$1.71M (+2.9%) vs. Q2 2023
- New holders
- 2
- 9 more added
- Sold out
- 11
- 14 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oliver Lagore Vanvalin Investment Group | 100 | $310 | 0.00% | +100 | New |
| Qube Research & Technologies Ltd | 194 | $601 | 0.00% | +194 | New |
| UBS Group AG | 1,693 | $5.25K | 0.00% | −1,644−49.3% | Reduced |
| Bank of America Corp | 1,955 | $6.06K | 0.00% | −11,721−85.7% | Reduced |
| BNP Paribas Arbitrage, SA | 2,100 | $6.51K | 0.00% | −8,710−80.6% | Reduced |
| National Bank of Canada | 3,850 | $11.3K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 10,500 | $32.5K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 13,080 | $40.5K | 0.00% | 00.0% | Unchanged |
| Beta Wealth Group, Inc. | 14,127 | $43.8K | 0.03% | 00.0% | Unchanged |
| PVG Asset Management Corp | 15,405 | $47.8K | 0.33% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 17,293 | $53.6K | 0.00% | +6,180+55.6% | Added |
| Geode Capital Management, LLC | 17,576 | $54.5K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 18,974 | $58.8K | 0.00% | +918+5.1% | Added |
| State Street Corp | 21,611 | $67.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 27,588 | $85.5K | 0.00% | +2,412+9.6% | Added |
| Clear Creek Financial Management, LLC | 31,429 | $97.4K | 0.02% | −500−1.6% | Reduced |
| LMR Partners LLP | 38,495 | $119.3K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 41,109 | $127.4K | 0.00% | −4,585−10.0% | Reduced |
| Gsa Capital Partners LLP | 48,796 | $151.0K | 0.01% | −17,544−26.4% | Reduced |
| Dimensional Fund Advisors LP | 86,839 | $269.1K | 0.00% | −93,148−51.8% | Reduced |
| Marshall Wace, LLP | 113,187 | $350.9K | 0.00% | −53,914−32.3% | Reduced |
| Valeo Financial Advisors, LLC | 120,699 | $374.2K | 0.02% | +2,000+1.7% | Added |
| BIT Capital GmbH | 207,276 | $642.6K | 0.09% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 244,356 | $757.5K | 0.00% | −2,807−1.1% | Reduced |
| BML Capital Management, LLC | 272,500 | $844.8K | 0.78% | 00.0% | Unchanged |
| Citadel Advisors LLC | 296,307 | $918.6K | 0.00% | −173,443−36.9% | Reduced |
| Boxer Capital, LLC | 309,007 | $957.9K | 0.05% | −389,854−55.8% | Reduced |
| Affinity Asset Advisors, LLC | 335,068 | $1.04M | 0.34% | +35,000+11.7% | Added |
| Lion Point Capital, LP | 450,207 | $1.40M | 1.28% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 462,828 | $1.43M | 0.53% | +2,412+0.5% | Added |
| Barclays PLC | 645,490 | $2.00M | 0.00% | −155,286−19.4% | Reduced |
| Morgan Stanley | 700,616 | $2.17M | 0.00% | −104,423−13.0% | Reduced |
| Alta Fundamental Advisers LLC | 1,176,189 | $3.65M | 2.13% | +278,228+31.0% | Added |
| Bleichroeder LP | 1,326,085 | $4.11M | 1.01% | 00.0% | Unchanged |
| Millennium Management LLC | 1,695,291 | $5.26M | 0.01% | −55,877−3.2% | Reduced |
| VR Adviser, LLC | 2,208,812 | $6.85M | 0.72% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 2,558,724 | $7.93M | 0.00% | +3,437+0.1% | Added |
| BlackRock Inc. | 2,780,740 | $8.62M | 0.00% | +129,540+4.9% | Added |
| RTW Investments, LP | 3,256,102 | $10.1M | 0.21% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −232,659−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −108,766−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −52,186−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −25,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −23,261−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,957−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,743−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,588−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −172−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |